4
Changes in Ownership
Rapport Therapeutics, Inc. Filed Acc 0001193125-25-324826
Chief Executive Officer sold 10,916 shares at an average $29.64 ($323,508)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ceesay Abraham Chief Executive Officer | 2025-12-17 | Sale 10b5-1 | −2,441 | $28.84 | $70,393 | 571,305 | D |
| Ceesay Abraham Chief Executive Officer | 2025-12-17 | Sale 10b5-1 | −2,792 | $30.04 | $83,862 | 568,513 | D |
| Ceesay Abraham Chief Executive Officer | 2025-12-17 | Sale 10b5-1 | −600 | $31.04 | $18,622 | 567,913 | D |
| Ceesay Abraham Chief Executive Officer | 2025-12-17 | Sale 10b5-1 | −2,147 | $28.84 | $61,925 | 33,831 | I |
| Ceesay Abraham Chief Executive Officer | 2025-12-17 | Sale 10b5-1 | −2,421 | $30.04 | $72,722 | 31,410 | I |
| Ceesay Abraham Chief Executive Officer | 2025-12-17 | Sale 10b5-1 | −515 | $31.04 | $15,985 | 30,895 | I |
| Open-market sales · 10,916 sh · avg $29.64 · $323,508 | |||||||
Loading xslF345X05/ownership.xml…